BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 9424006)

  • 1. Experimental Validation of the MRcollar: An MR Compatible Applicator for Deep Heating in the Head and Neck Region.
    Sumser K; Drizdal T; Bellizzi GG; Hernandez-Tamames JA; van Rhoon GC; Paulides MM
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses.
    Datta NR; Kok HP; Crezee H; Gaipl US; Bodis S
    Front Oncol; 2020; 10():819. PubMed ID: 32596144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status quo and directions in deep head and neck hyperthermia.
    Paulides MM; Verduijn GM; Van Holthe N
    Radiat Oncol; 2016 Feb; 11():21. PubMed ID: 26868027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined chemoradiotherapy with local microwave hyperthermia for treatment of T3N0 laryngeal carcinoma: a retrospective study with long-term follow-up.
    Kouloulias V; Triantopoulou S; Vrouvas J; Gennatas K; Ouzounoglou N; Kouvaris J; Karaiskos P; Aggelakis P; Antypas C; Zygogianni A; Papavasiliou K; Platoni K; Kelekis N
    Acta Otorhinolaryngol Ital; 2014 Jun; 34(3):167-73. PubMed ID: 24882925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin, hyperthermia, and radiation (trimodal therapy) in patients with locally advanced head and neck tumors: a phase I-II study.
    Amichetti M; Graiff C; Fellin G; Pani G; Bolner A; Maluta S; Valdagni R
    Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):801-7. PubMed ID: 8344849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neck.
    Varveris H; Mazonakis M; Vlachaki M; Kachris S; Lyraraki E; Zoras O; Maris T; Froudarakis M; Velegrakis J; Perysinakis C; Damilakis J; Samonis G
    Oncol Rep; 2003; 10(1):185-95. PubMed ID: 12469168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermoradiotherapy with combined interstitial and external hyperthermia in advanced tumours in the head and neck with depth > or = 3 cm.
    Engin K; Tupchong L; Waterman FM; Nerlinger RT; Hoh LL; McFarlane JD; Leeper DB
    Int J Hyperthermia; 1993; 9(5):645-54. PubMed ID: 8245577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermia and radiotherapy for inoperable squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site.
    Amichetti M; Romano M; Cristoforetti L; Valdagni R
    Int J Hyperthermia; 2000; 16(1):85-93. PubMed ID: 10669319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients.
    Valdagni R; Amichetti M
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):163-9. PubMed ID: 8270437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperfractionated radiation in combination with local hyperthermia in the treatment of advanced squamous cell carcinoma of the head and neck: a phase I-II study.
    Amichetti M; Romano M; Busana L; Bolner A; Fellin G; Pani G; Tomio L; Valdagni R
    Radiother Oncol; 1997 Nov; 45(2):155-8. PubMed ID: 9424006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
    Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.
    Szturz P; Wouters K; Kiyota N; Tahara M; Prabhash K; Noronha V; Castro A; Licitra L; Adelstein D; Vermorken JB
    Oncologist; 2017 Sep; 22(9):1056-1066. PubMed ID: 28533474
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.